Drug Profile
Anti-C6 polyclonal antibody
Alternative Names: Polyclonal rat-antirat C6 antibodyLatest Information Update: 10 Aug 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Polyclonal antibodies
- Mechanism of Action Complement C6 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Xenotransplant rejection
Most Recent Events
- 10 Aug 1998 No-Development-Reported for Xenotransplant rejection in USA (Unknown route)
- 27 Mar 1996 New profile
- 27 Mar 1996 Preclinical development for Xenotransplant rejection in USA (Unknown route)